KeloidNCT03460431
A Study Using Fractional Carbon Dioxide and Long Pulsed Neodymium-yttrium Aluminum Garnet Lasers in Treatment of Keloids
A study testing fractional CO2 laser 10,600nm and Nd YAG laser1064 nm in people with Keloid, run by Cairo University.
Trial summary
clinical comparative study comparing the effectiveness of fractional CO2, long pulsed Nd YAG and their combination in collagen remodeling in keloid clinically, biochemically and histopathologically Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Keloid
- What is being tested?
- fractional CO2 laser 10,600nm and Nd YAG laser1064 nm
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- 1 Jul 2014to 30 Jun 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients with keloid scars of at least 6 months duration.
- No limitations regarding sex of the patients.
- Patients with three or more lesions 2 to 3 cm apart or patients having a large sized lesion.
Who cannot join
- Patients who had received any form of treatment during the last four weeks prior to treatment such as intralesional steroids or a laser procedure during the last six months.
- Patients with active skin infections e.g. herpes or autoimmune disease.
- Patients with previous history of adverse outcome related to laser therapy.
- Recent use of Isotretinoin (within 6 months prior to the procedure).
- Patients with known allergies to lidocaine.
- Smoking, pregnancy
- Patients with unrealistic expectations
About this study
Official title: Evaluation of Fractional CO2 and Non Ablative Long Pulsed Nd YAG Lasers Alone and in Combination in Treatment of Keloids
clinical comparative study comparing the effectiveness of fractional CO2, long pulsed Nd YAG and their combination in collagen remodeling in keloid clinically, biochemically and histopathologically
Read the detailed description
Patients The study included 30 Egyptian patients with keloid scar recruited from the Out Patient Clinic, Dermatology Department, Cairo University.
Methodology
Patients:
- Thirty patients with keloid scar(s) were included in the study
- Every patient was subjected to the following:
- Complete history taking: History of disease onset, course and duration, family history as well as history of any systemic or dermatological disease interfering with the eligibility of participation in the study. Thirty patients were included in the study which is a clinical comparative study comparing the effectiveness of fractional CO2, long pulsed Nd YAG and their combination in collagen remodeling in keloid clinically in all the included patients and biochemically and immunohistochemically fifteen patient
- Full clinical examination:
- General examination to determine any systemic or dermatological disease that might preclude the patient from participation in the study such as collagen disease.
- Local examination to determine Fitzpatrick skin color of the patient and the site and extent of the scar to be treated. Methods:
- Cases with multiple keloid scars three lesions 2 to 3 cm apart from each other were selected and labeled. The first one (lesion A) was treated using fractional CO2 laser 10,600 nm, the second (lesion B) long pulsed Nd YAG laser 1064 nm, while the last (lesion C) combined fractional CO2 followed by Nd YAG lasers after half an hour were used
- patients who had a large sized lesion, the lesion was divided into three equal parts 2 to 3 cm apart from each other, they were labeled as areas A, B and C then subjected to the same treatment modalities as mentioned in case of multiple lesions.
- Patients received 4 treatment sessions 4 to 8 weeks apart. Laser modalities and parameters
- Topical anesthesia (lidocaine 2.5% and prilocaine 2.5%) was applied to the working area 30 to 60 minutes before the sessions, washed off and properly dried before the procedure.
- Ablative fractional 10,600 nm carbon dioxide laser (DEKA smartxide DOT, Italy) and long pulsed Nd-YAG (DEKA synchro FT) were used in the treatment sessions with the following parameters Fractional CO2 Stacking: 5, Power: 20 Watt, Dwell time: 1000 micro second, Spacing : 800 micro meter fluence: 40 j/cm2 Pulse duration: 0.3 milli second Spot size: 5 mm Passes: 3. Assessment Assessment was done before treatment every session and one months after the final laser treatment. Clinical assessment was done for all patients while histopathological and biochemical assessment were done only in 15 patients.
- Clinical evaluation Clinical assessment was fulfilled via calculating the scores of both the Vancouver Scar Scale; and the Patient and Observer Scar Assessment Scale. Patients were assessed every session, any side effects were reported, e.g pain, swelling, infection, hyper pigmentation or hypo pigmentation.
- Histopathological and biochemical evaluation Fifteen patients were randomly selected and subjected to the pre and post treatment biopsies :
- Pretreatment biopsy: Three mm punch skin biopsy was taken from the keloid (any lesion A, B, or C) before starting treatment sessions ●Post treatment biopsies: Each lesion (A, B, C) was biopsied separately (3 mm punch biopsy), one month after last treatment session. Biopsies of controls ●parts of excess skin from 12 patients undergoing abdominoplasty were used as controls for levels of TGFβ1 and TGFβ3. Procedure
- Biopsies were fixed in 10 % neutral buffered formalin, and then embedded in paraffin blocks. Sections were prepared for routine staining by H\&E. Other sections were prepared for histochemical staining of collagen fibres using Masson's trichrome stain and elastic fibres using orcein stain
- All sections were examined using a Zeiss, Primo star light microscope (Zeiss, Germany). The microscope has an integrated camera by which photomicrographs depicting the various histopathological and histochemical findings were obtained. All photomicrographs presented in the thesis are according to their original magnification.
- Evaluation of elastic fibres in orcein stained sections: Orcein stained sections were graded according to the grading criteria proved by Ozog et al. in 2013 for the appearance of the dermal elastic tissue as follows:
0 normal
- short fragmented elastic fibres
- intermediate between 1 and 3
- fibrillar elastic fibres, parallel to epidermis
- intermediate between 3 and 5
- absent or nearly absent.
Image analyzer evaluation (morphometric study):
The area percent of collagen and elastic fibres were quantitatively evaluated in Masson's trichrome and orcein stained sections respectively at magnification X100 in 5 non overlapping fields for all patients. Image analysis was done using Leica Qwin 500C image analyzer computer system (England) present in the Histology Department, Faculty of Medicine, Cairo University .
- Conditions
- Keloid
- Being tested
- fractional CO2 laser 10,600nm, Nd YAG laser1064 nm
- Medical subject headings
- Keloid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
fractional CO2 laser 10,600nmDevice
fractional CO2 laser 10,600nm session, every month for 4 months
Nd YAG laser1064 nmDevice
Nd YAG laser1064 nm laser session, every month for 4 months
| Study group | Role | What they receive |
|---|---|---|
| fractional CO2 laser 10,600nm | Experimental | fractional CO2 laser 10,600nm one session every month for 4 months Receives: Device: fractional CO2 laser 10,600nm |
| Nd YAG laser 1064nm | Experimental | Nd YAG laser 1064nm Receives: Device: Nd YAG laser1064 nm |
| combined two laser types | Experimental | combined fractional CO2 laser 10,600nm and Nd YAG laser 1064nm lasers treatment to keloid Receives: Device: fractional CO2 laser 10,600nm; Device: Nd YAG laser1064 nm |
What is being measured
The primary outcome is the main question the study is designed to answer.
comparison between different laser modalities in treatment of keloids clinically
assessed by Patient and Observer Scar assessment Scale
Measured: 5 months
comparison between different laser modalities in treatment of keloids morphometrically
assessed by Quantitative morphometric analysis using Leica Qwin 500 Image Analyzer (LEICA Imaging Systems Ltd, Cambridge, England) measuring area percent of collagen and elastin fibers in micrometer squared
Measured: 5 months
comparison between different laser modalities in treatment of keloids biochemically
assessed by level of transforming growth factor beta 1 and 3 using Human TGF-B ELISA kit provided by ID labs Biotechnology London, ON, Canada.measurement unit is nano gram per gram tissue
Measured: 5 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Mar 2018
- Study start1 Jul 2014
- Primary completion27 Feb 2017
- Study completion30 Jun 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for KeloidStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed Foad Mohamed, Cairo University
- Investigators
- Shereen O Tawfik, MD, Study director, professor of Dermatology.faculty of medicine. Cairo university
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03460431
- Sponsor's protocol ID
- 3060114
- Status last verified
- Mar 2018
- First submitted
- 23 Jan 2018
- Last updated
- 9 Mar 2018
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Fractional CO2 and Non Ablative Long Pulsed Nd YAG Lasers Alone and in Combination in Treatment of Keloids
- ClinicalTrials.gov ID
- NCT03460431
- Acronym / sponsor ID
- 3060114
- Conditions
- Keloid
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 1 Jul 2014 (actual)
- Primary completion
- 27 Feb 2017 (actual)
- Study completion
- 30 Jun 2017 (actual)
- First posted
- 9 Mar 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
clinical comparative study comparing the effectiveness of fractional CO2, long pulsed Nd YAG and their combination in collagen remodeling in keloid clinically, biochemically and histopathologically
Detailed description
Patients The study included 30 Egyptian patients with keloid scar recruited from the Out Patient Clinic, Dermatology Department, Cairo University.
Methodology
Patients:
- Thirty patients with keloid scar(s) were included in the study
- Every patient was subjected to the following:
- Complete history taking: History of disease onset, course and duration, family history as well as history of any systemic or dermatological disease interfering with the eligibility of participation in the study. Thirty patients were included in the study which is a clinical comparative study comparing the effectiveness of fractional CO2, long pulsed Nd YAG and their combination in collagen remodeling in keloid clinically in all the included patients and biochemically and immunohistochemically fifteen patient
- Full clinical examination:
- General examination to determine any systemic or dermatological disease that might preclude the patient from participation in the study such as collagen disease.
- Local examination to determine Fitzpatrick skin color of the patient and the site and extent of the scar to be treated. Methods:
- Cases with multiple keloid scars three lesions 2 to 3 cm apart from each other were selected and labeled. The first one (lesion A) was treated using fractional CO2 laser 10,600 nm, the second (lesion B) long pulsed Nd YAG laser 1064 nm, while the last (lesion C) combined fractional CO2 followed by Nd YAG lasers after half an hour were used
- patients who had a large sized lesion, the lesion was divided into three equal parts 2 to 3 cm apart from each other, they were labeled as areas A, B and C then subjected to the same treatment modalities as mentioned in case of multiple lesions.
- Patients received 4 treatment sessions 4 to 8 weeks apart. Laser modalities and parameters
- Topical anesthesia (lidocaine 2.5% and prilocaine 2.5%) was applied to the working area 30 to 60 minutes before the sessions, washed off and properly dried before the procedure.
- Ablative fractional 10,600 nm carbon dioxide laser (DEKA smartxide DOT, Italy) and long pulsed Nd-YAG (DEKA synchro FT) were used in the treatment sessions with the following parameters Fractional CO2 Stacking: 5, Power: 20 Watt, Dwell time: 1000 micro second, Spacing : 800 micro meter fluence: 40 j/cm2 Pulse duration: 0.3 milli second Spot size: 5 mm Passes: 3. Assessment Assessment was done before treatment every session and one months after the final laser treatment. Clinical assessment was done for all patients while histopathological and biochemical assessment were done only in 15 patients.
- Clinical evaluation Clinical assessment was fulfilled via calculating the scores of both the Vancouver Scar Scale; and the Patient and Observer Scar Assessment Scale. Patients were assessed every session, any side effects were reported, e.g pain, swelling, infection, hyper pigmentation or hypo pigmentation.
- Histopathological and biochemical evaluation Fifteen patients were randomly selected and subjected to the pre and post treatment biopsies :
- Pretreatment biopsy: Three mm punch skin biopsy was taken from the keloid (any lesion A, B, or C) before starting treatment sessions ●Post treatment biopsies: Each lesion (A, B, C) was biopsied separately (3 mm punch biopsy), one month after last treatment session. Biopsies of controls ●parts of excess skin from 12 patients undergoing abdominoplasty were used as controls for levels of TGFβ1 and TGFβ3. Procedure
- Biopsies were fixed in 10 % neutral buffered formalin, and then embedded in paraffin blocks. Sections were prepared for routine staining by H\&E. Other sections were prepared for histochemical staining of collagen fibres using Masson's trichrome stain and elastic fibres using orcein stain
- All sections were examined using a Zeiss, Primo star light microscope (Zeiss, Germany). The microscope has an integrated camera by which photomicrographs depicting the various histopathological and histochemical findings were obtained. All photomicrographs presented in the thesis are according to their original magnification.
- Evaluation of elastic fibres in orcein stained sections: Orcein stained sections were graded according to the grading criteria proved by Ozog et al. in 2013 for the appearance of the dermal elastic tissue as follows:
0 normal
- short fragmented elastic fibres
- intermediate between 1 and 3
- fibrillar elastic fibres, parallel to epidermis
- intermediate between 3 and 5
- absent or nearly absent.
Image analyzer evaluation (morphometric study):
The area percent of collagen and elastic fibres were quantitatively evaluated in Masson's trichrome and orcein stained sections respectively at magnification X100 in 5 non overlapping fields for all patients. Image analysis was done using Leica Qwin 500C image analyzer computer system (England) present in the Histology Department, Faculty of Medicine, Cairo University .
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| fractional CO2 laser 10,600nm | Experimental | Device: fractional CO2 laser 10,600nmfractional CO2 laser 10,600nm one session every month for 4 months |
| Nd YAG laser 1064nm | Experimental | Device: Nd YAG laser1064 nmNd YAG laser 1064nm |
| combined two laser types | Experimental | Device: fractional CO2 laser 10,600nm, Device: Nd YAG laser1064 nmcombined fractional CO2 laser 10,600nm and Nd YAG laser 1064nm lasers treatment to keloid |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients with keloid scars of at least 6 months duration.
- No limitations regarding sex of the patients.
- Patients with three or more lesions 2 to 3 cm apart or patients having a large sized lesion.
Key exclusion criteria (7 listed)
- Patients who had received any form of treatment during the last four weeks prior to treatment such as intralesional steroids or a laser procedure during the last six months.
- Patients with active skin infections e.g. herpes or autoimmune disease.
- Patients with previous history of adverse outcome related to laser therapy.
- Recent use of Isotretinoin (within 6 months prior to the procedure).
- Patients with known allergies to lidocaine.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| fractional CO2 laser 10,600nmfractional CO2 laser 10,600nm session, every month for 4 months | Device | combined two laser types, fractional CO2 laser 10,600nm |
| Nd YAG laser1064 nmNd YAG laser1064 nm laser session, every month for 4 months | Device | Nd YAG laser 1064nm, combined two laser types |
Primary outcome
comparison between different laser modalities in treatment of keloids clinically
Time frame: 5 months
assessed by Patient and Observer Scar assessment Scale
comparison between different laser modalities in treatment of keloids morphometrically
Time frame: 5 months
assessed by Quantitative morphometric analysis using Leica Qwin 500 Image Analyzer (LEICA Imaging Systems Ltd, Cambridge, England) measuring area percent of collagen and elastin fibers in micrometer squared
comparison between different laser modalities in treatment of keloids biochemically
Time frame: 5 months
assessed by level of transforming growth factor beta 1 and 3 using Human TGF-B ELISA kit provided by ID labs Biotechnology London, ON, Canada.measurement unit is nano gram per gram tissue
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2018.
- Individual participant dataSharing planned: Undecided
Related trials for Keloid
Not yet recruiting
Fractional Radiofrequency With Streroids Versus Fractional CO2 Laser With Steroids in the Treatment of Keloids
Keloids
Active, not recruiting
Transdermal Versus Intralesional Betamethasone for Keloids
Keloid
RecruitingPhase 2
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
Keloid
Recruiting
Radiotherapy for Keloids
Keloid
RecruitingObservational study
Keloid Pathogenesis And Fibroblast Activation Study
Keloids, Fibroblast
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Shereen O Tawfik, MD study director
professor of Dermatology.faculty of medicine. Cairo university
Questions about this trial
What is this clinical trial studying?
A study testing fractional CO2 laser 10,600nm and Nd YAG laser1064 nm in people with Keloid, run by Cairo University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
comparison between different laser modalities in treatment of keloids clinically (time frame: 5 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2018.